Hepcidin and Erythroferrone in the Anemia of Low-Risk Myelodysplastic Syndromes

被引：1
|
作者：
Oarbeascoa, Gillen [1 ]
Redondo, Sara [2 ]
Jose Moran-Jimenez, Maria [3 ]
Domingo, Amalia [1 ]
Munoz-Linares, Cristina [2 ]
Isabel Moreno-Carralero, Maria [4 ]
Maria Bellon, Jose [5 ]
del Campo Rincon, Juan Francisco [2 ]
Luis Diez-Martin, Jose [1 ,5 ,6 ]
Font, Patricia [1 ,5 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Hematol Dept, Madrid, Spain
[2] Hosp Univ Henares, Hematol Dept, Madrid, Spain
[3] Hosp 12 Octubre I 12, Inst Invest Sanitaria, Madrid, Spain
[4] Hosp 12 Octubre Imas12, Inst Invest Sanitaria, Madrid, Spain
[5] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[6] Univ Complutense Madrid, Dept Med, Madrid, Spain
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3085
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes
    Tehranchi, R
    MEDICAL ONCOLOGY, 2006, 23 (01) : 37 - 49
  • [32] Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies
    Molica, Matteo
    Rossi, Marco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (04) : 233 - 241
  • [33] Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes
    Xiaomei Ma
    Rong Wang
    Naomi Galili
    Susan T. Mayne
    Sa A. Wang
    Herbert Yu
    Azra Raza
    Cancer Causes & Control, 2011, 22 : 623 - 629
  • [34] Erythroferrone and hepcidin levels in children with iron deficiency anemia
    Dulkadir, Ramazan
    Saltoglu, Gamze Turna
    Gunes, Ali
    BMC PEDIATRICS, 2024, 24 (01)
  • [35] Erythroferrone and hepcidin levels in children with iron deficiency anemia
    Ramazan Dulkadir
    Gamze Turna Saltoğlu
    Ali Güneş
    BMC Pediatrics, 24
  • [36] Darbepoetin alfa for treating anemia in patients with low-risk myelodysplastic syndromes: Exploratory analysis of baseline predictors of response.
    Gabrilove, J.
    Paquette, R.
    Lyons, R.
    Mushtaq, C.
    Sekeres, M.
    Lam, H.
    Dreiling, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 356S - 356S
  • [37] An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
    Teodorescu, Patric
    Pasca, Sergiu
    Choi, Inyoung
    Shams, Cynthia
    Dalton, W. Brian
    Gondek, Lukasz P.
    DeZern, Amy E.
    Ghiaur, Gabriel
    HAEMATOLOGICA, 2024, 109 (01) : 337 - 342
  • [38] Moving low-risk myelodysplastic syndromes from humans to mice: is it truly that simple?
    Coriu, Daniel
    Stancioaica, Maria -Camelia
    HAEMATOLOGICA, 2024, 109 (01) : 8 - 10
  • [39] The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances
    Randall, Michael P.
    DeZern, Amy E.
    CANCER JOURNAL, 2023, 29 (03): : 152 - 159
  • [40] High-dose rHuEPO for the treatment of patients with low-risk myelodysplastic syndromes
    Latagliata, R.
    Oliva, E.
    Volpicelli, P.
    Napoleone, L.
    Carmosino, I.
    Breccia, M.
    Stefanizzi, C.
    Vincelli, I.
    Alati, C.
    Vozella, F.
    Nobile, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2009, 33 : S121 - S121
12345